Therefore, we presume that TPH2 hypofunction and MAO-A hyperfunction may induce the change in the regulatory mechanism of the 5-HT metabolic pathway observed in the FH/HamSlc rats. The gene discussed is MAOA; the disease is familial hyperaldosteronism.